A phase II trial of paclitaxel, 5-fluorouracil (5-FU) and cisplatin in patients with metastatic or recurrent gastric cancer.
作者： Gun Hi Kang , Gwang Sil Kim , Hyo Rak Lee , Young Jin Yuh , Sung Rok Kim
DOI: 10.4143/CRT.2008.40.3.106
关键词:
摘要: Purpose We wanted to assess the effectiveness and safety of combination chemotherapy with paclitaxel, 5-fluorouracil (5-FU) cisplatin for treating advanced gastric cancer.
koreascience.or.kr参考文章(21)
Jaffer A. Ajani, Paul F. Mansfield, Yehuda Z. Patt, Pamela Dumas, Jackie Fairweather, Richard Pazdur, Phase II study of Taxol in patients with advanced gastric carcinoma. The cancer journal from Scientific American. ,vol. 4, pp. 269- 274 ,(1998)
E K Rowinsky, M R Gilbert, W P McGuire, D A Noe, L B Grochow, A A Forastiere, D S Ettinger, B G Lubejko, B Clark, S E Sartorius, Sequences of Taxol and Cisplatin: A Phase I and Pharmacologic Study Journal of Clinical Oncology. ,vol. 9, pp. 1692- 1703 ,(1991) , 10.1200/JCO.1991.9.9.1692
B. Glimelius, K. Hoffman, U. Haglund, O. Nyrén, P.O. Sjödén, Initial or delayed chemotherapy with best supportive care in advanced gastric cancer Annals of Oncology. ,vol. 5, pp. 189- 190 ,(1994) , 10.1093/OXFORDJOURNALS.ANNONC.A058778
A Sulkes, , J Smyth, C Sessa, LY Dirix, JB Vermorken, S Kaye, J Wanders, H Franklin, N LeBail, J Verweij, Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group. British Journal of Cancer. ,vol. 70, pp. 380- 383 ,(1994) , 10.1038/BJC.1994.310
Noe Kyeong Kim, Young Suk Park, Dae Seog Heo, Cheolwon Suh, Si Young Kim, Keun Chil Park, Yoon Koo Kang, Dong Bok Shin, Heung Tae Kim, Hyo Jin Kim, Won Ki Kang, Chang In Suh, Yung-Jue Bang, A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer Cancer. ,vol. 71, pp. 3813- 3818 ,(1993) , 10.1002/1097-0142(19930615)71:12<3813::AID-CNCR2820711205>3.0.CO;2-5
S Pyrhönen, T Kuitunen, P Nyandoto, M Kouri, Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. British Journal of Cancer. ,vol. 71, pp. 587- 591 ,(1995) , 10.1038/BJC.1995.114
Yeul H Kim, Sang W Shin, Byung S Kim, Jin H Kim, Jong G Kim, Young J Mok, Chong S Kim, Ho S Rhyu, Jin H Hyun, Jun S Kim, None, Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma Cancer. ,vol. 85, pp. 295- 301 ,(1999) , 10.1002/(SICI)1097-0142(19990115)85:2<295::AID-CNCR5>3.0.CO;2-H
Murray F. Brennan, Current status of surgery for gastric cancer: a review Gastric Cancer. ,vol. 8, pp. 64- 70 ,(2005) , 10.1007/S10120-005-0319-6
Myung-Hee Shin, Hyun-Kyung Oh, Yoon-Ok Ahn, [Ten Year Trend of Cancer Incidence in Seoul, Korea: 1993--2002] Journal of Preventive Medicine and Public Health. ,vol. 41, pp. 92- 99 ,(2008) , 10.3961/JPMPH.2008.41.2.92
Atsushi Ohtsu, Yasuhiro Shimada, Kuniaki Shirao, Narikazu Boku, Ichinosuke Hyodo, Hiroshi Saito, Noboru Yamamichi, Yoshinori Miyata, Nobumasa Ikeda, Seiichiro Yamamoto, Haruhiko Fukuda, Shigeaki Yoshida, Randomized Phase III Trial of Fluorouracil Alone Versus Fluorouracil Plus Cisplatin Versus Uracil and Tegafur Plus Mitomycin in Patients With Unresectable, Advanced Gastric Cancer: The Japan Clinical Oncology Group Study (JCOG9205) Journal of Clinical Oncology. ,vol. 21, pp. 54- 59 ,(2003) , 10.1200/JCO.2003.04.130